MLKNA — MedLink International Share Price
- $0.00m
- $1.95m
- $6.00m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0 | ||
Price to Tang. Book | 0 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0 | ||
EV to EBITDA | 2.18 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 3.51% | ||
Return on Equity | 9.37% | ||
Operating Margin | 3.38% |
Financial Summary
Year End 31st Dec | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011E | 2012E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 0.01 | 0.28 | 0.09 | 0.52 | 6 | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
MedLink International, Inc. is a healthcare information enterprise system business focused on the physician sector. MedLink sells and supports an electronic health record (EHR) application, including practice management for physician practices. MedLink’s flagship offering is the CCHIT Certified 08 Ambulatory MedLink TotalOffice EHR, a healthcare information enterprise system that provides physician practices with a practice management, clinical decision support and EHR solution. MedLink also offers a lite version of its application, the MedLink EHR Lite, which provides physicians with basic EHR functionality at no cost to physicians. Through business partnerships, MedLink offers physician practices billing, collection, hardware and network infrastructure and use of the TotalOffice EHR, all for a fixed fee determined by the practice’s annual billing revenue. In July 2010, MedLink International Inc. acquired LabTestPortal, a direct to consumer laboratory testing platform.
Directors
- Last Annual
- December 31st, 2010
- Last Interim
- December 31st, 2010
- Incorporated
- October 6th, 2005
- Public Since
- September 17th, 2001
- No. of Employees
- 34
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 47,595,066
- Address
- 1 Roebling Court, RONKONKOMA, 11779-9202
- Web
- Phone
- +1 6313428800
- Auditors
- RBSM LLP
Similar to MLKNA
1606
Pink Sheets on Nasdaq
Ablaze Technologies
Pink Sheets on Nasdaq
Accelerated Technologies Holding
Pink Sheets on Nasdaq
Acorn Energy
Pink Sheets on Nasdaq
Advanced Voice Recognition Systems
Pink Sheets on Nasdaq
FAQ
As of Today at 22:01 UTC, shares in MedLink International are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in MedLink International last closed at $0.00 and the price had moved by over the past 365 days. In terms of relative price strength the MedLink International share price has underperformed the S&P500 Index by -16.07% over the past year.
There is no consensus recommendation for this security.
MedLink International does not currently pay a dividend.
MedLink International does not currently pay a dividend.
MedLink International does not currently pay a dividend.
To buy shares in MedLink International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in MedLink International had a market capitalisation of $0.00m.
Here are the trading details for MedLink International:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: MLKNA
Based on an overall assessment of its quality, value and momentum MedLink International is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MedLink International. Over the past six months, its share price has underperformed the S&P500 Index by -99.09%.
As of the last closing price of $0.00, shares in MedLink International were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The MedLink International PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
MedLink International's management team is headed by:
- Ray Vuono - CHM
- Jameson Rose - CFO
- Konrad Kim - CTO
- Michael Carvo - IND